SEARCH OUR PRODUCT CATALOG

AKAP13-RET Fusion FISH Probe

The AKAP13-RET Fusion FISH Probe is used to confirm a fusion of the AKAP13 and RET genes. The fusion of the AKAP13 and RET genes has been associated with Thyroid Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
AKAP13-RET-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
AKAP13-RET-20-RERE 20 (40 μL) 200 μL
AKAP13-RET-20-REOR 20 (40 μL) 200 μL
AKAP13-RET-20-REGO 20 (40 μL) 200 μL
AKAP13-RET-20-REGR 20 (40 μL) 200 μL
AKAP13-RET-20-REAQ 20 (40 μL) 200 μL
AKAP13-RET-20-ORRE 20 (40 μL) 200 μL
AKAP13-RET-20-OROR 20 (40 μL) 200 μL
AKAP13-RET-20-ORGO 20 (40 μL) 200 μL
AKAP13-RET-20-ORAQ 20 (40 μL) 200 μL
AKAP13-RET-20-GORE 20 (40 μL) 200 μL
AKAP13-RET-20-GOOR 20 (40 μL) 200 μL
AKAP13-RET-20-GOGO 20 (40 μL) 200 μL
AKAP13-RET-20-GOGR 20 (40 μL) 200 μL
AKAP13-RET-20-GOAQ 20 (40 μL) 200 μL
AKAP13-RET-20-GRRE 20 (40 μL) 200 μL
AKAP13-RET-20-GROR 20 (40 μL) 200 μL
AKAP13-RET-20-GRGO 20 (40 μL) 200 μL
AKAP13-RET-20-GRGR 20 (40 μL) 200 μL
AKAP13-RET-20-GRAQ 20 (40 μL) 200 μL
AKAP13-RET-20-AQRE 20 (40 μL) 200 μL
AKAP13-RET-20-AQOR 20 (40 μL) 200 μL
AKAP13-RET-20-AQGO 20 (40 μL) 200 μL
AKAP13-RET-20-AQGR 20 (40 μL) 200 μL
AKAP13-RET-20-AQAQ 20 (40 μL) 200 μL

RET Gene Summary

This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]

Gene Name: Ret Proto-oncogene

Chromosome: CHR10: 43572516 -43625797

Locus: 10q11.21

AKAP13 Gene Summary

The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms containing c-terminal dbl oncogene homology (DH) and pleckstrin homology (PH) domains. The DH domain is associated with guanine nucleotide exchange activation for the Rho/Rac family of small GTP binding proteins, resulting in the conversion of the inactive GTPase to the active form capable of transducing signals. The PH domain has multiple functions. Therefore, these isoforms function as scaffolding proteins to coordinate a Rho signaling pathway, function as protein kinase A-anchoring proteins and, in addition, enhance ligand-dependent activity of estrogen receptors alpha and beta. [provided by RefSeq, Jul 2012]

Gene Name: A-kinase Anchoring Protein 13

Chromosome: CHR15: 85923870 -86292586

Locus: 15q25.3

Gene Diseases

The AKAP13 RET Fusion has been associated with the following diseases:

Disease Name
Thyroid Carcinoma

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

Customer Publications

There are currently no FISH related publications for this probe.